Centessa Pharmaceuticals
CNTA
#3288
Rank
NZ$7.55 B
Marketcap
NZ$51.08
Share price
-1.37%
Change (1 day)
65.13%
Change (1 year)

Revenue for Centessa Pharmaceuticals (CNTA)

Revenue in 2025 (TTM): NZ$26.45 Million

According to Centessa Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$25.97 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of NZ$10.83 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Centessa Pharmaceuticals from 2022 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$26.45 M
2024 N/A-100%
2023 NZ$10.83 M
2022 N/A